Cell penetrating peptides
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
May 23, 2017
Issued Date -
Aug 27, 2015
app pub date -
Sep 12, 2013
filing date -
Sep 13, 2012
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The present invention relates to a short cell penetrating peptide derived from the Epstein-Barr virus basic leucine zipper transcriptional activator (ZEBRA), optionally linked to a cargo molecule. It also relates to a complex comprising the cell penetrating peptide and a cargo molecule, as well as cells loaded with the complex and the use thereof in therapy and diagnosis.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully